Transcarent to acquire Accolade
coverager - Jan 10, 2025
Transcarent will acquire Accolade for $7.03 per share in cash, which represents a total equity value of approximately $621M....
Recommended Articles
Posted: Dec 21, 2025
The company’s platform is being adopted by national health plans and focuses on improving payment ac...
Posted: Dec 21, 2025
The role is focused on coordinating the firm’s risk, capital, and advisory capabilities for digital...
Posted: Dec 21, 2025
Financial terms were not disclosed....